Cellectar Biosciences, Inc. (CLRB) › Operating IncomeCellectar Biosciences, Inc. (CLRB) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$4.19M2011: -$7.04M2012: -$8.75M2013: -$12.40M2014: -$9.89M2015: -$8.76M2016: -$9.45M2017: -$13.60M2018: -$13.33M2019: -$14.18M2020: -$15.29M2021: -$24.13M2022: -$28.81M2023: -$38.96M2024: -$51.78M2025: -$22.98M-$22.98M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$22.98M+55.6%2024-$51.78M-32.9%2023-$38.96M-35.2%2022-$28.81M-19.4%2021-$24.13M-57.8%2020-$15.29M-7.8%2019-$14.18M-6.4%2018-$13.33M+2.0%2017-$13.60M-43.9%2016-$9.45M-7.9%2015-$8.76M+11.5%2014-$9.89M+20.2%2013-$12.40M-41.7%2012-$8.75M-24.4%2011-$7.04M-67.8%2010-$4.19M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share